GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion Biotech AS (NAS:EVAX) » Definitions » PB Ratio

EVAX (Evaxion Biotech AS) PB Ratio : 29.22 (As of Mar. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Evaxion Biotech AS PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-04), Evaxion Biotech AS's share price is $1.87. Evaxion Biotech AS's Book Value per Share for the quarter that ended in Sep. 2024 was $0.06. Hence, Evaxion Biotech AS's PB Ratio of today is 29.22.

The historical rank and industry rank for Evaxion Biotech AS's PB Ratio or its related term are showing as below:

EVAX' s PB Ratio Range Over the Past 10 Years
Min: 2.68   Med: 14.07   Max: 230.47
Current: 31.5

During the past 7 years, Evaxion Biotech AS's highest PB Ratio was 230.47. The lowest was 2.68. And the median was 14.07.

EVAX's PB Ratio is ranked worse than
97.59% of 1285 companies
in the Biotechnology industry
Industry Median: 2.34 vs EVAX: 31.50

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Evaxion Biotech AS was -11.00% per year. The lowest was -11.00% per year. And the median was -11.00% per year.

Back to Basics: PB Ratio


Evaxion Biotech AS PB Ratio Historical Data

The historical data trend for Evaxion Biotech AS's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evaxion Biotech AS PB Ratio Chart

Evaxion Biotech AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - 3.16 5.16 -

Evaxion Biotech AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3.02 12.52 242.97

Competitive Comparison of Evaxion Biotech AS's PB Ratio

For the Biotechnology subindustry, Evaxion Biotech AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evaxion Biotech AS's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion Biotech AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where Evaxion Biotech AS's PB Ratio falls into.



Evaxion Biotech AS PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Evaxion Biotech AS's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=1.87/0.064
=29.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Evaxion Biotech AS  (NAS:EVAX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Evaxion Biotech AS PB Ratio Related Terms

Thank you for viewing the detailed overview of Evaxion Biotech AS's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evaxion Biotech AS Business Description

Traded in Other Exchanges
N/A
Address
Dr. Neergaards Vej 5f, Hoersholm, DNK, DK-2970
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.